Antiarrhythmic Safety in Pregnancy — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Flecainide may be used after specialist risk–benefit assessment; beta-blockers generally have more pregnancy safety experience
Pregnancy does not make every antiarrhythmic drug absolutely contraindicated. Flecainide has specialist uses for selected maternal and fetal tachyarrhythmias, but treatment should follow an individual maternal–fetal risk assessment; beta-blockers such as metoprolol have broader pregnancy experience. Amiodarone is generally reserved for exceptional, life-threatening circumstances.
Reference: NICE cardiovascular conditions guidance: https://www.nice.org.uk/guidance/conditions-and-diseases/cardiovascular-conditions